Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Laboratory Corp of America Holdings, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Laboratory Corp of America Holdings, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Laboratory Corp of America Holdings, Medical Equipment, Deal Details 16
Asset Purchase 16
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 16
Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 18
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 19
Gamma-Dynacare Medical Acquires Medical Labs Division Of Warnex 20
Venture Financing 21
OmniSeq Plans to Raise Funds through Series B Financing 21
Sera Prognostics Raises USD40 Million in Series C Financing 22
Seventh Sense Biosystems Raises USD10 Million in Series C Financing 23
Ativa Medical Raises USD15 Million in Series B Financing 25
Vivify Health Raises Funds in Series B Venture Financing 26
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 27
Flatiron Health Raises US$130 Million In Series B Financing 29
Flatiron Health Raises US$8 Million In Series A Financing 30
Private Equity 32
Shore Capital Invests In ClearPath Diagnostics 32
Partnerships 33
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 33
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 34
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 35
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 36
LipoScience Enters Into Licensing Agreement With Cleveland Clinic 37
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer’s Diagnostic Technology 38
Sequenom Enters Into Licensing Agreement With LifeCodexx 39
MC10 Enters into Partnership with LabCorp 40
OmniSeq Enters into Distribution Agreement with Laboratory Corp of America 41
Sera Prognostics Enters into Agreement with LabCorp 42
Interpace Diagnostics Extends Agreement with LabCorp 43
Sequenom enters into an Agreement with University of California 44
Sysmex Enters into Co-Development Agreement with LabCorp 45
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 46
Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 47
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 48
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 49
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 50
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 51
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 52
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 53
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 54
Emdeon Enters Into Strategic Alliance With LabCorp 55
Merger 56
instaCare Receives Merger Offer From A NASDAQ Traded Company 56
New England Biolabs Enters Into Licensing Agreement With Sequenom 57
Equity Offering 58
MC10 Raises Funds through Private Placement of Shares 58
LipoScience Completes IPO For US$52 Million 59
Sequenom Completes Public Offering Of Common Stock For US$62 Million 61
Debt Offering 63
LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 63
LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 65
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 67
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 69
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 71
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 73
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 75
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 77
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 79
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 80
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 82
Asset Transactions 84
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 84
Marken Acquires European Kit Building Operation Facility From LabCorp 85
Acquisition 86
LabCorp Acquires Pathology Associates Medical Labs from Providence Health & Services and Catholic Health Initiatives 86
LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 88
LabCorp Acquires Sequenom 89
LabCorp Acquires Covance for USD6.1 Billion 91
LabCorp Acquires Bode Technology from SolutionPoint 93
LabCorp Acquires LipoScience for USD85.3 Million 94
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 96
Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 97
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 98
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 99
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 101
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 102
Pathology Holdings Acquires Central Coast Clinical Labs 105
Laboratory Corp of America Holdings – Key Competitors 106
Laboratory Corp of America Holdings – Key Employees 107
Laboratory Corp of America Holdings – Locations And Subsidiaries 108
Head Office 108
Other Locations & Subsidiaries 108
Recent Developments 113
Strategy And Business Planning 113
Jun 14, 2017: Covance Opens State-of-the-Art Laboratory for Companion Diagnostics 113
Apr 21, 2017: Covance to Expand Large-Molecule Development Capabilities in the UK 114
Financial Announcements 115
Oct 25, 2017: LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance 115
Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 117
Apr 25, 2017: Laboratory Corporation of America Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance 120
Feb 16, 2017: Laboratory Corporation of America Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance 122
Oct 26, 2016: Laboratory Corporation of America Holdings Announces 2016 Third Quarter Results and Updates 2016 Guidance 125
Jul 27, 2016: Laboratory Corporation of America Holdings Announces 2016 Second Quarter Results and Raises 2016 Guidance 128
Apr 25, 2016: Laboratory Corporation of America Holdings Announces 2016 First Quarter Results and Raises 2016 Guidance 130
Feb 18, 2016: Laboratory Corporation of America Holdings Announces 2015 Fourth Quarter and Full Year Results and Provides 2016 Guidance 132
Corporate Communications 135
Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 135
Jul 18, 2017: LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 136
Mar 29, 2017: LabCorp Promotes Executive Gary Huff to CEO of LabCorp Diagnostics, One of the Company’s Two Primary Business Segments 137
Sep 20, 2016: LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development 138
Apr 11, 2016: LabCorp Hires Jonathan Zung as Group President of Clinical Development and Commercialization Services for Covance Drug Development 139
Jan 07, 2016: LabCorp Announces New Board Member 140
Legal and Regulatory 141
Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 141
Oct 03, 2016: Oxford Immunotec Announces Favorable Decision from U.S. District Court of Massachusetts in Patent Infringement Litigation 142
Sep 01, 2016: Oxford Immunotec Announces Favorable Recommendation by the Magistrate Judge in Patent Infringement Litigation 143
Product News 144
Nov 16, 2017: Cority Enhances Clinical Testing Solution with LabCorp Interface 144
Sep 14, 2017: LabCorp Presents Nine Studies, Including Novel Research on Improving Genetic Counseling Quality, at the National Society of Genetic Counselors Annual Conference 145
Apr 28, 2017: LabCorp to Exclusively Offer the M3 Checklist, a Multi-Condition Mental Health Screening Tool 146
Jun 01, 2016: One Year After Launch, BRCA Share Open Data Initiative Reveals New Findings on BRCA Gene Mutations Linked to Hereditary Breast and Ovarian Cancer Risk 148
Jan 04, 2016: Proprietary LabCorp Clinical Decision Support Report Improves Adherence to Chronic Kidney Disease Treatment Guidelines 150
Other Significant Developments 151
Sep 25, 2017: LabCorp Objects to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests; Calls for Delay in Implementation to Avoid Significant Harm to Medicare Beneficiaries 151
Jul 11, 2017: LabCorp and Novant Health Extend Laboratory Services Agreement 152
Jun 28, 2017: Walgreens and LabCorp Collaborate to Bring Patient Service Centers for Laboratory Testing to Select Walgreens Stores 153
Mar 14, 2016: Covance Announces Mobile Health Solutions to Support Use of Mobile Technology in Clinical Trials 154
Appendix 155
Methodology 155
About GlobalData 155
Contact Us 155
Disclaimer 155
Laboratory Corp of America Holdings, Medical Equipment, Key Facts, 2016 2
Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Laboratory Corp of America Holdings, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Laboratory Corp of America Holdings, Deals By Market, 2011 to YTD 2017 11
Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 16
Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 18
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 19
Gamma-Dynacare Medical Acquires Medical Labs Division Of Warnex 20
OmniSeq Plans to Raise Funds through Series B Financing 21
Sera Prognostics Raises USD40 Million in Series C Financing 22
Seventh Sense Biosystems Raises USD10 Million in Series C Financing 23
Ativa Medical Raises USD15 Million in Series B Financing 25
Vivify Health Raises Funds in Series B Venture Financing 26
Seventh Sense Biosystems Raises USD16 Million in Series B Financing 27
Flatiron Health Raises US$130 Million In Series B Financing 29
Flatiron Health Raises US$8 Million In Series A Financing 30
Shore Capital Invests In ClearPath Diagnostics 32
Sequenom Enters into Licensing Agreement with Mayo Medical Labs 33
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 34
Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 35
Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 36
LipoScience Enters Into Licensing Agreement With Cleveland Clinic 37
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 38
Sequenom Enters Into Licensing Agreement With LifeCodexx 39
MC10 Enters into Partnership with LabCorp 40
OmniSeq Enters into Distribution Agreement with Laboratory Corp of America 41
Sera Prognostics Enters into Agreement with LabCorp 42
Interpace Diagnostics Extends Agreement with LabCorp 43
Sequenom enters into an Agreement with University of California 44
Sysmex Enters into Co-Development Agreement with LabCorp 45
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 46
Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 47
Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 48
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 49
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 50
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 51
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 52
Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 53
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 54
Emdeon Enters Into Strategic Alliance With LabCorp 55
instaCare Receives Merger Offer From A NASDAQ Traded Company 56
New England Biolabs Enters Into Licensing Agreement With Sequenom 57
MC10 Raises Funds through Private Placement of Shares 58
LipoScience Completes IPO For US$52 Million 59
Sequenom Completes Public Offering Of Common Stock For US$62 Million 61
LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 63
LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 65
LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 67
LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 69
LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 71
LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 73
LabCorp Completes Public Offering Of Notes Due 2018 For US$400 Million 75
LabCorp Completes Public Offering Of Notes Due 2023 For US$300 Million 77
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 79
LabCorp Completes Public Offering Of Senior Notes Due 2017 For US$500 Million 80
LabCorp Completes Public Offering Of Senior Notes Due 2022 For US$500 Million 82
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 84
Marken Acquires European Kit Building Operation Facility From LabCorp 85
LabCorp Acquires Pathology Associates Medical Labs from Providence Health & Services and Catholic Health Initiatives 86
LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 88
LabCorp Acquires Sequenom 89
LabCorp Acquires Covance for USD6.1 Billion 91
LabCorp Acquires Bode Technology from SolutionPoint 93
LabCorp Acquires LipoScience for USD85.3 Million 94
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 96
Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 97
LabCorp Acquires Minority Stake In SynapDx For US$2 Million 98
LabCorp Completes Acquisition Of Medtox Scientific For US$241 Million 99
Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 101
LabCorp Completes Acquisition Of Orchid Cellmark For US$85 Million 102
Pathology Holdings Acquires Central Coast Clinical Labs 105
Laboratory Corp of America Holdings, Key Competitors 106
Laboratory Corp of America Holdings, Key Employees 107
Laboratory Corp of America Holdings, Other Locations 108
Laboratory Corp of America Holdings, Subsidiaries 109